Security key
74365A309
Protalix BioTherapeutics, Inc. - Common Stock (PLX)
CUSIP: 74365A309
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 4,467,337
- Total 13F value
- $8,398,680
- Share change
- +1,083,092
- Put/Call ratio
- 13%
- SEC-reported price per share
- $1.88
- Number of holders
- 46
- Value change
- +$2,201,784
- Number of buys
- 20
- Number of sells
- 14
- Shares outstanding
- 80,610,558
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
46
Top holders
10
PLX full security history
Ownership snapshot
Full 13F holder table
Protalix BioTherapeutics, Inc. SEC filings
Protalix BioTherapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of PLX - Protalix BioTherapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RENAISSANCE TECHNOLOGIES LLC
Disclosed value leader
RENAISSANCE TECHNOLOGIES LLC
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
Lead comparable stake: 1.2%
Showing 1-6 of 15 holder rows.
Quick read
RENAISSANCE TECHNOLOGIES LLC leads the comparable SEC ownership view at 1.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RENAISSANCE TECHNOLOGIES LLC's linked filing trail.
Comparable ownership
Top 5
RENAISSANCE TECHNOLOGIES LLC
1.2%
GSA CAPITAL PARTNERS LLP
0.54%
MILLENNIUM MANAGEMENT LLC
0.46%
Stratos Wealth Partners, LTD.
0.33%
BRIDGEWAY CAPITAL MANAGEMENT, LLC
0.23%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
1.2%
|
$975,018
955,900 shares
|
— | 30 Sep 2024 |
| GSA CAPITAL PARTNERS LLP |
13F
Company
|
0.54%
|
$444,000
435,213 shares
|
— | 30 Sep 2024 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
0.46%
|
$381,232
373,757 shares
|
— | 30 Sep 2024 |
| Stratos Wealth Partners, LTD. |
13F
Company
|
0.33%
|
$275,400
270,000 shares
|
— | 30 Sep 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.23%
|
$187,466
183,790 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
0.22%
|
$182,359
178,784 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
46
Shares
4,467,337
Rows available
46
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
43
Q4 2024 holders
46
Holder diff
3
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|